Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Wareham

Showing results (21-30 of 70) with videos related to

Pageof 7
Sort By:
International Journal of Antimicrobial Agents|July 11, 2013
In vitro activity of the novel monosulfactam BAL30072 alone and in combination with meropenem versus a diverse collection of important Gram-negative pathogensMichael Hornsey, Lynette Phee, William Stubbings, et al.
The Journal of Antimicrobial Chemotherapy|October 5, 2013
Carbapenemase-producing Enterobacteriaceae and non-Enterobacteriaceae from animals and the environment: an emerging public health risk of our own making?Neil Woodford, David W Wareham, Beatriz Guerra, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 7, 2002
99mTc-labeled antimicrobial peptides for detection of bacterial and Candida albicans infectionsSatya S Das, David W Wareham, Keith E Britton
Genome Announcements|April 8, 2017
Draft Genome Sequence of a Canine Isolate of Methicillin-Resistant <i>Staphylococcus haemolyticus</i>David C Bean, Sarah M Wigmore, David W Wareham
Pathogens (Basel, Switzerland)|November 27, 2024
<i>Aeromonas</i> and <i>mcr</i>-3: A Critical Juncture for Transferable Polymyxin Resistance in Gram-Negative BacteriaNathan L McDonald, David W Wareham, David C Bean
Antimicrobial Agents and Chemotherapy|April 12, 2012
In vitro activity of telavancin in combination with colistin versus Gram-negative bacterial pathogensMichael Hornsey, Christopher Longshaw, Lynette Phee, et al.
The Journal of Antimicrobial Chemotherapy|March 27, 2018
Direct detection of carbapenem resistance determinants in clinical specimens using immunochromatographic lateral flow devicesDavid W Wareham, Lynette M Phee, Muhd Haziq F Abdul Momin
Journal of Global Antimicrobial Resistance|March 3, 2019
Hypermucoviscous polymyxin-resistant Klebsiella pneumoniae from Kolkata, India: Genomic and phenotypic analysisDavid C Bean, Anuradha Agarwal, Benny P Cherian, et al.
Antimicrobial Agents and Chemotherapy|May 20, 2015
Colistin and Fusidic Acid, a Novel Potent Synergistic Combination for Treatment of Multidrug-Resistant Acinetobacter baumannii InfectionsLynette M Phee, Jonathan W Betts, Binutha Bharathan, et al.
The Journal of Antimicrobial Chemotherapy|August 20, 2014
Activity of the type I signal peptidase inhibitor MD3 against multidrug-resistant Gram-negative bacteria alone and in combination with colistinYoann Personne, Michael A Curtis, David W Wareham, et al.
Pageof 7

Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
International Journal of Antimicrobial Agents|July 11, 2013
In vitro activity of the novel monosulfactam BAL30072 alone and in combination with meropenem versus a diverse collection of important Gram-negative pathogensMichael Hornsey, Lynette Phee, William Stubbings, et al.
The Journal of Antimicrobial Chemotherapy|October 5, 2013
Carbapenemase-producing Enterobacteriaceae and non-Enterobacteriaceae from animals and the environment: an emerging public health risk of our own making?Neil Woodford, David W Wareham, Beatriz Guerra, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 7, 2002
99mTc-labeled antimicrobial peptides for detection of bacterial and Candida albicans infectionsSatya S Das, David W Wareham, Keith E Britton
Genome Announcements|April 8, 2017
Draft Genome Sequence of a Canine Isolate of Methicillin-Resistant <i>Staphylococcus haemolyticus</i>David C Bean, Sarah M Wigmore, David W Wareham
Pathogens (Basel, Switzerland)|November 27, 2024
<i>Aeromonas</i> and <i>mcr</i>-3: A Critical Juncture for Transferable Polymyxin Resistance in Gram-Negative BacteriaNathan L McDonald, David W Wareham, David C Bean
Antimicrobial Agents and Chemotherapy|April 12, 2012
In vitro activity of telavancin in combination with colistin versus Gram-negative bacterial pathogensMichael Hornsey, Christopher Longshaw, Lynette Phee, et al.
The Journal of Antimicrobial Chemotherapy|March 27, 2018
Direct detection of carbapenem resistance determinants in clinical specimens using immunochromatographic lateral flow devicesDavid W Wareham, Lynette M Phee, Muhd Haziq F Abdul Momin
Journal of Global Antimicrobial Resistance|March 3, 2019
Hypermucoviscous polymyxin-resistant Klebsiella pneumoniae from Kolkata, India: Genomic and phenotypic analysisDavid C Bean, Anuradha Agarwal, Benny P Cherian, et al.
Antimicrobial Agents and Chemotherapy|May 20, 2015
Colistin and Fusidic Acid, a Novel Potent Synergistic Combination for Treatment of Multidrug-Resistant Acinetobacter baumannii InfectionsLynette M Phee, Jonathan W Betts, Binutha Bharathan, et al.
The Journal of Antimicrobial Chemotherapy|August 20, 2014
Activity of the type I signal peptidase inhibitor MD3 against multidrug-resistant Gram-negative bacteria alone and in combination with colistinYoann Personne, Michael A Curtis, David W Wareham, et al.
Pageof 7